These results from predominantly pre-menopausal women with breast cancer suggest that it is not merely the presence or absence of AR expression but the relative activity with ER, as well as the hormonal milieu of the patient that determines clinical outcomes, indicating that both context and interactions ultimately influence tumor behavior. The gene discussed is ESR1; the disease is breast carcinoma.